Perspective: nonalcoholic fatty liver disease and cardiovascular risk

P. J. Nestel; R.P. Mensink

doi:10.1097/MOL.0b013e32835c0834

Perspective: nonalcoholic fatty liver disease and cardiovascular risk

P. J. Nestel^*, R.P. Mensink

^*Corresponding author for this work

Humane Biologie

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

Nonalcoholic fatty liver disease (NAFLD) has emerged as a clear risk factor for cardiovascular risk. Through its association with metabolic syndrome including insulin resistance and type 2 diabetes, NAFLD certainly has strong indirect associations with cardiovascular risk. Recent population studies have strengthened the association with prevalent coronary heart disease. Investigative cardiology has shown that NAFLD is also associated with markers of subclinical atherosclerosis, such as diminished endothelial function and carotid artery intima-media thickening. Though causality between NAFLD and cardiovascular disease can only be tested in a clinical trial, these recent findings do emphasize the need to develop strategies including nutritional that may prevent NAFLD.

Original language	English
Pages (from-to)	1-3
Journal	Current Opinion in Lipidology
Volume	24
Issue number	1
DOIs	https://doi.org/10.1097/MOL.0b013e32835c0834
Publication status	Published - 1 Jan 2013

Access to Document

10.1097/MOL.0b013e32835c0834

Cite this

@article{a30cbc3999264f48a5cd11a823d482e1,

title = "Perspective: nonalcoholic fatty liver disease and cardiovascular risk",

abstract = "Nonalcoholic fatty liver disease (NAFLD) has emerged as a clear risk factor for cardiovascular risk. Through its association with metabolic syndrome including insulin resistance and type 2 diabetes, NAFLD certainly has strong indirect associations with cardiovascular risk. Recent population studies have strengthened the association with prevalent coronary heart disease. Investigative cardiology has shown that NAFLD is also associated with markers of subclinical atherosclerosis, such as diminished endothelial function and carotid artery intima-media thickening. Though causality between NAFLD and cardiovascular disease can only be tested in a clinical trial, these recent findings do emphasize the need to develop strategies including nutritional that may prevent NAFLD.",

author = "Nestel, {P. J.} and R.P. Mensink",

year = "2013",

month = jan,

day = "1",

doi = "10.1097/MOL.0b013e32835c0834",

language = "English",

volume = "24",

pages = "1--3",

journal = "Current Opinion in Lipidology",

issn = "0957-9672",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "1",

}

TY - JOUR

T1 - Perspective: nonalcoholic fatty liver disease and cardiovascular risk

AU - Nestel, P. J.

AU - Mensink, R.P.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Nonalcoholic fatty liver disease (NAFLD) has emerged as a clear risk factor for cardiovascular risk. Through its association with metabolic syndrome including insulin resistance and type 2 diabetes, NAFLD certainly has strong indirect associations with cardiovascular risk. Recent population studies have strengthened the association with prevalent coronary heart disease. Investigative cardiology has shown that NAFLD is also associated with markers of subclinical atherosclerosis, such as diminished endothelial function and carotid artery intima-media thickening. Though causality between NAFLD and cardiovascular disease can only be tested in a clinical trial, these recent findings do emphasize the need to develop strategies including nutritional that may prevent NAFLD.

AB - Nonalcoholic fatty liver disease (NAFLD) has emerged as a clear risk factor for cardiovascular risk. Through its association with metabolic syndrome including insulin resistance and type 2 diabetes, NAFLD certainly has strong indirect associations with cardiovascular risk. Recent population studies have strengthened the association with prevalent coronary heart disease. Investigative cardiology has shown that NAFLD is also associated with markers of subclinical atherosclerosis, such as diminished endothelial function and carotid artery intima-media thickening. Though causality between NAFLD and cardiovascular disease can only be tested in a clinical trial, these recent findings do emphasize the need to develop strategies including nutritional that may prevent NAFLD.

U2 - 10.1097/MOL.0b013e32835c0834

DO - 10.1097/MOL.0b013e32835c0834

M3 - Comment/Letter to the editor

SN - 0957-9672

VL - 24

SP - 1

EP - 3

JO - Current Opinion in Lipidology

JF - Current Opinion in Lipidology

IS - 1

ER -